23rd Jun 2006 14:25
Cambridge Antibody Tech Group PLC23 June 2006 Cambridge Antibody Technology Group plc ("CAT") CAT (LSE: CAT; NASDAQ: CATG) announces that, following the recommended offermade by AstraZeneca UK Limited for CAT becoming unconditional in all respects on22 June 2006, G H R Musker, S F Grady, I M D Brimicombe and A C N Kemp wereappointed Directors of CAT with effect from 22 June 2006. No further informationis required to be disclosed pursuant to Listing Rule 9.6.13. For further information please contact: Rowena Gardner, Director of Corporate Communications +44 (0) 1223 898 622 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CATCo